Compugen (CGEN) Other Accumulated Expenses (2020 - 2021)
Compugen's (CGEN) quarterly Other Accumulated Expenses came in at $4.8 million in Q4 2021, down 2.91% year-on-year from $4.9 million in Q4 2020, and down 2.91% quarter-over-quarter from $4.9 million in Q4 2020.
Compugen (CGEN) Other Accumulated Expenses (2020 - 2021) Analysis & Trends
Compugen has disclosed Other Accumulated Expenses across 2 years of filings, most recently posting $4.8 million for Q4 2021.
- Other Accumulated Expenses for Q4 2021 came in at $4.8 million, down 2.91% year-over-year; the trailing twelve-month figure through Dec 2021 was $4.8 million (down 2.91% YoY), and the FY2021 annual result was $4.8 million, down 2.91% from the prior year.
- Other Accumulated Expenses came in at $4.8 million for Q4 2021 at Compugen, down from $4.9 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $4.9 million in Q4 2020 to a low of $4.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.78 Mn |
| Dec 31, 2020 | 4.92 Mn |